| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.987 | 0.001 | 0.987 | Androgen antagonist | 0.912 0.002 CID_253325 | ||
| 0.972 | 0.004 | 0.972 | Antiinflammatory | 0.969 0.004 CID_253325 | ||
| 0.937 | 0.001 | 0.937 | Androgen agonist | 0.775 0.001 CID_253325 | ||
| 0.937 | 0.002 | 0.937 | Hypoxia-inducible factor 1 alpha inhibitor | 0.844 0.003 CID_253325 | ||
| 0.922 | 0 | 0.922 | Transcortin receptor antagonist | 0.862 0 CID_253325 | ||
| 0.923 | 0.004 | 0.923 | Transcription factor NF kappa B inhibitor | 0.916 0.005 CID_253325 | ||
| 0.863 | 0.002 | 0.863 | Antipruritic | 0.733 0.003 CID_253325 | ||
| 0.817 | 0.001 | 0.817 | Progesterone antagonist | 0.747 0.001 CID_253325 | ||
| 0.8 | 0.001 | 0.8 | Glucocorticoid antagonist | 0.67 0.001 CID_253325 | ||
| 0.794 | 0.002 | 0.831 | Aromatase inhibitor | 0.831 0.001 CID_253325 | CID_253325 | |
| 0.79 | 0.005 | 0.79 | Toll-Like receptor 7 agonist | 0.768 0.005 CID_253325 | ||
| 0.785 | 0.005 | 0.785 | Toll-Like receptor agonist | 0.761 0.005 CID_253325 | ||
| 0.773 | 0.003 | 0.773 | Diuretic | 0.701 0.004 CID_253325 | ||
| 0.782 | 0.019 | 0.782 | Apoptosis agonist | 0.758 0.022 CID_253325 | ||
| 0.749 | 0.001 | 0.749 | Glucocorticoid agonist | 0.693 0.001 CID_253325 | ||
| 0.748 | 0.005 | 0.748 | Cholesterol antagonist | 0.691 0.009 CID_253325 | ||
| 0.744 | 0.003 | 0.744 | Anesthetic general | 0.663 0.004 CID_253325 | ||
| 0.744 | 0.004 | 0.744 | Immunosuppressant | 0.735 0.004 CID_253325 | ||
| 0.739 | 0.001 | 0.739 | Aldosterone antagonist | 0.586 0.001 CID_253325 | ||
| 0.713 | 0.001 | 0.713 | Lipocortins synthesis antagonist | 0.687 0.001 CID_253325 | ||
| 0.72 | 0.022 | 0.72 | Caspase 9 stimulant | 0.715 0.022 CID_253325 | ||
| 0.678 | 0.001 | 0.678 | Interferon gamma antagonist | 0.63 0.002 CID_253325 | ||
| 0.658 | 0.012 | 0.658 | Aldehyde oxidase inhibitor | 0.551 0.026 CID_253325 | ||
| 0.623 | 0.003 | 0.623 | Interleukin 8 antagonist | 0.32 0.004 CID_253325 | ||
| 0.624 | 0.005 | 0.65 | P-glycoprotein inhibitor | 0.65 0.004 CID_253325 | CID_253325 | |
| 0.559 | 0.004 | 0.559 | NOS3 expression enhancer | 0.457 0.006 CID_253325 | ||
| 0.528 | 0.003 | 0.528 | Estrogen receptor alpha antagonist | 0.412 0.004 CID_253325 | ||
| 0.519 | 0.004 | 0.52 | Interleukin 6 antagonist | 0.52 0.004 CID_253325 | CID_253325 | |
| 0.512 | 0 | 0.512 | Arachidonic acid antagonist | 0.447 0 CID_253325 | ||
| 0.512 | 0.001 | 0.512 | Anabolic | 0.35 0.001 CID_253325 | ||
| 0.505 | 0.004 | 0.515 | Sodium/bile acid cotransporter inhibitor | 0.515 0.003 CID_253325 | CID_253325 | |
| 0.493 | 0.004 | 0.493 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.426 0.006 CID_253325 | ||
| 0.496 | 0.014 | 0.496 | DNA synthesis inhibitor | 0.445 0.017 CID_253325 | ||
| 0.484 | 0.017 | 0.537 | Nitric oxide antagonist | 0.537 0.013 CID_253325 | CID_253325 | |
| 0.481 | 0.021 | 0.481 | Interleukin antagonist | 0.42 0.028 CID_253325 | ||
| 0.455 | 0.003 | 0.455 | Mineralocorticoid receptor antagonist | 0.377 0.003 CID_253325 | ||
| 0.43 | 0.002 | 0.43 | 5-Alpha-reductase inhibitor | 0.357 0.002 CID_253325 | ||
| 0.432 | 0.004 | 0.432 | Estrogen antagonist | 0.373 0.005 CID_253325 | ||
| 0.413 | 0.007 | 0.413 | Alkylator | 0.403 0.007 CID_253325 | ||
| 0.41 | 0.004 | 0.41 | Cholesterol synthesis inhibitor | 0.366 0.006 CID_253325 | ||
| 0.435 | 0.03 | 0.525 | Apoptosis antagonist | 0.525 0.017 CID_253325 | CID_253325 | |
| 0.401 | 0 | 0.401 | Corticosteroid-like | 0.306 0.001 CID_253325 | ||
| 0.438 | 0.04 | 0.438 | Immunostimulant | 0.387 0.054 CID_253325 | ||
| 0.417 | 0.023 | 0.417 | Interleukin 2 agonist | 0.362 0.04 CID_253325 | ||
| 0.391 | 0.012 | 0.391 | Melanin inhibitor | 0.24 0.03 CID_253325 | ||
| 0.379 | 0.004 | 0.379 | Estrogen agonist | 0.335 0.005 CID_253325 | ||
| 0.396 | 0.036 | 0.396 | Antioxidant | 0.385 0.037 CID_253325 | ||
| 0.39 | 0.031 | 0.39 | DNA damaging | 0.292 0.06 CID_253325 | ||
| 0.364 | 0.012 | 0.364 | Lipid peroxidase inhibitor | 0.302 0.019 CID_253325 | ||
| 0.344 | 0.002 | 0.344 | RNA-directed RNA polymerase stimulant | 0.279 0.002 CID_253325 | ||
| 0.38 | 0.05 | 0.446 | Caspase 3 stimulant | 0.446 0.031 CID_253325 | CID_253325 | |
| 0.406 | 0.087 | 0.406 | Cyclophilin D inhibitor | 0.346 0.125 CID_253325 | ||
| 0.32 | 0.006 | 0.32 | Topoisomerase II alpha inhibitor | 0.288 0.008 CID_253325 | ||
| 0.313 | 0.002 | 0.313 | Progesterone agonist | 0.279 0.002 CID_253325 | ||
| 0.328 | 0.023 | 0.346 | Hepatoprotectant | 0.346 0.02 CID_253325 | CID_253325 | |
| 0.319 | 0.016 | 0.319 | Monophenol monooxygenase inhibitor | 0.227 0.027 CID_253325 | ||
| 0.335 | 0.037 | 0.335 | Angiogenesis stimulant | 0.312 0.045 CID_253325 | ||
| 0.313 | 0.016 | 0.313 | Topoisomerase II inhibitor | 0.278 0.02 CID_253325 | ||
| 0.294 | 0.001 | 0.294 | Lipocortins synthesis agonist | 0.248 0.001 CID_253325 | ||
| 0.326 | 0.045 | 0.326 | Tumour necrosis factor alpha release inhibitor | 0.289 0.058 CID_253325 | ||
| 0.367 | 0.093 | 0.408 | Antibacterial | 0.408 0.073 CID_253325 | CID_253325 | |
| 0.271 | 0.004 | 0.271 | Estradiol 17 beta-dehydrogenase inhibitor | 0.171 0.005 CID_253325 | ||
| 0.273 | 0.009 | 0.273 | Farnesoid X receptor antagonist | 0.26 0.01 CID_253325 | ||
| 0.266 | 0.004 | 0.266 | Estrogen receptor alpha agonist | 0.206 0.004 CID_253325 | ||
| 0.261 | 0.003 | 0.261 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.091 0.005 CID_253325 | ||
| 0.267 | 0.014 | 0.267 | DNA intercalator | 0.227 0.019 CID_253325 | ||
| 0.277 | 0.026 | 0.277 | Neurotrophic factor enhancer | 0.27 0.028 CID_253325 | ||
| 0.267 | 0.017 | 0.267 | Adenylate cyclase inhibitor | 0.151 0.044 CID_253325 | ||
| 0.252 | 0.007 | 0.252 | Estrogen receptor beta antagonist | 0.207 0.009 CID_253325 | ||
| 0.249 | 0.007 | 0.249 | AMP-activated protein kinase stimulant | 0.168 0.019 CID_253325 | ||
| 0.242 | 0.003 | 0.242 | 5-Alpha-reductase 1 inhibitor | 0.12 0.004 CID_253325 | ||
| 0.253 | 0.014 | 0.279 | Antineoplastic antibiotic | 0.279 0.011 CID_253325 | CID_253325 | |
| 0.298 | 0.083 | 0.306 | Immunomodulator | 0.306 0.079 CID_253325 | CID_253325 | |
| 0.234 | 0.02 | 0.234 | DNA polymerase I inhibitor | 0.212 0.025 CID_253325 | ||
| 0.208 | 0.003 | 0.208 | 5-Alpha-reductase 2 inhibitor | 0.107 0.005 CID_253325 | ||
| 0.203 | 0.005 | 0.203 | Estrogen receptor beta agonist | 0.165 0.006 CID_253325 | ||
| 0.198 | 0.003 | 0.198 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.18 0.003 CID_253325 | ||
| 0.212 | 0.019 | 0.212 | Interleukin 4 antagonist | 0.16 0.041 CID_253325 | ||
| 0.184 | 0.003 | 0.184 | Na+ K+ transporting ATPase inhibitor | 0.17 0.004 CID_253325 | ||
| 0.187 | 0.01 | 0.187 | Inducible nitric-oxide synthase inhibitor | 0.158 0.014 CID_253325 | ||
| 0.177 | 0.002 | 0.177 | Glucose-6-phosphate dehydrogenase inhibitor | 0.176 0.002 CID_253325 | ||
| 0.181 | 0.007 | 0.181 | Interleukin 5 antagonist | 0.144 0.013 CID_253325 | ||
| 0.193 | 0.021 | 0.193 | Microtubule formation inhibitor | 0.184 0.024 CID_253325 | ||
| 0.179 | 0.019 | 0.179 | Pregnane X receptor agonist | 0.177 0.021 CID_253325 | ||
| 0.155 | 0.006 | 0.155 | Glycine receptor antagonist | 0.132 0.013 CID_253325 | ||
| 0.163 | 0.015 | 0.163 | Toll-Like receptor 4 antagonist | 0.156 0.018 CID_253325 | ||
| 0.193 | 0.045 | 0.193 | Acetylcholine M1 receptor antagonist | 0.137 0.088 CID_253325 | ||
| 0.15 | 0.005 | 0.15 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.08 0.016 CID_253325 | ||
| 0.145 | 0.004 | 0.145 | Estrone sulfatase inhibitor | 0.128 0.004 CID_253325 | ||
| 0.188 | 0.049 | 0.188 | Amylase inhibitor | |||
| 0.161 | 0.022 | 0.161 | Ca2+-transporting ATPase inhibitor | 0.157 0.029 CID_253325 | ||
| 0.163 | 0.024 | 0.163 | Antineoplastic alkaloid | 0.159 0.025 CID_253325 | ||
| 0.143 | 0.008 | 0.143 | Glycine receptor agonist | 0.093 0.026 CID_253325 | ||
| 0.134 | 0.004 | 0.134 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.078 0.005 CID_253325 | ||
| 0.221 | 0.102 | 0.221 | Interleukin agonist | |||
| 0.161 | 0.046 | 0.161 | Adenylate cyclase stimulant | 0.156 0.053 CID_253325 | ||
| 0.116 | 0.004 | 0.116 | Nitric oxide donor | 0.112 0.005 CID_253325 | ||
| 0.168 | 0.056 | 0.168 | Protein kinase stimulant | 0.155 0.065 CID_253325 | ||
| 0.125 | 0.016 | 0.125 | Bile acid receptor antagonist | 0.113 0.026 CID_253325 | ||
| 0.171 | 0.071 | 0.179 | Phospholipase C inhibitor | 0.179 0.062 CID_253325 | CID_253325 | |
| 0.147 | 0.049 | 0.147 | Aldehyde dehydrogenase inhibitor | |||
| 0.153 | 0.056 | 0.153 | Bone formation stimulant | 0.109 0.096 CID_253325 | ||
| 0.134 | 0.048 | 0.134 | Topoisomerase I inhibitor | 0.108 0.064 CID_253325 | ||
| 0.087 | 0.005 | 0.087 | Pregnane X receptor antagonist | 0.074 0.011 CID_253325 | ||
| 0.144 | 0.065 | 0.159 | Neurotrophic factor | 0.159 0.052 CID_253325 | CID_253325 | |
| 0.125 | 0.047 | 0.126 | Expectorant | 0.126 0.047 CID_253325 | CID_253325 | |
| 0.105 | 0.034 | 0.108 | Transcription factor NF kappa B stimulant | 0.108 0.032 CID_253325 | CID_253325 | |
| 0.082 | 0.015 | 0.082 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.073 0.018 CID_253325 | ||
| 0.107 | 0.042 | 0.107 | ABCA1 expression enhancer | |||
| 0.119 | 0.055 | 0.122 | Mucolytic | 0.122 0.053 CID_253325 | CID_253325 | |
| 0.079 | 0.016 | 0.079 | Heme oxygenase stimulant | 0.074 0.02 CID_253325 | ||
| 0.093 | 0.033 | 0.093 | T cell inhibitor | 0.083 0.056 CID_253325 | ||
| 0.09 | 0.038 | 0.09 | Keratolytic | 0.083 0.045 CID_253325 | ||
| 0.143 | 0.093 | 0.143 | Growth hormone agonist | 0.121 0.12 CID_253325 | ||
| 0.066 | 0.016 | 0.066 | Adenosine deaminase inhibitor | 0.049 0.032 CID_253325 | ||
| 0.042 | 0.004 | 0.042 | Hedgehog signaling activator | 0.039 0.005 CID_253325 | ||
| 0.091 | 0.054 | 0.091 | Ornithine decarboxylase inhibitor | 0.075 0.073 CID_253325 | ||
| 0.056 | 0.02 | 0.056 | Microtubule stabilization | 0.055 0.022 CID_253325 | ||
| 0.049 | 0.015 | 0.052 | Farnesoid X receptor agonist | 0.052 0.014 CID_253325 | CID_253325 | |
| 0.149 | 0.116 | 0.149 | Non-steroidal antiinflammatory agent | |||
| 0.173 | 0.141 | 0.173 | Peptidyltransferase inhibitor | 0.165 0.157 CID_253325 | ||
| 0.158 | 0.129 | 0.199 | Hypolipemic | 0.199 0.095 CID_253325 | CID_253325 | |
| 0.108 | 0.081 | 0.108 | Acetylcholine muscarinic antagonist | |||
| 0.083 | 0.057 | 0.083 | Estrogen-related receptor beta agonist | |||
| 0.155 | 0.13 | 0.155 | Growth factor agonist | |||
| 0.159 | 0.135 | 0.159 | Free radical scavenger | |||
| 0.107 | 0.086 | 0.107 | Cholinergic antagonist | |||
| 0.026 | 0.006 | 0.026 | Progesterone receptor B antagonist | 0.023 0.009 CID_253325 | ||
| 0.023 | 0.005 | 0.025 | Telomerase stimulant | 0.025 0.004 CID_253325 | CID_253325 | |
| 0.104 | 0.087 | 0.104 | Acetylcholine antagonist | |||
| 0.095 | 0.078 | 0.095 | Beta glucuronidase inhibitor | |||
| 0.019 | 0.003 | 0.019 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.018 0.003 CID_253325 | ||
| 0.024 | 0.011 | 0.024 | Vitamin D receptor antagonist | 0.023 0.013 CID_253325 | ||
| 0.079 | 0.066 | 0.079 | GABA A receptor agonist | |||
| 0.016 | 0.004 | 0.016 | Progesterone receptor A antagonist | |||
| 0.055 | 0.045 | 0.15 | HIV-1 integrase (Strand Transfer) inhibitor | 0.15 0.013 CID_253325 | CID_253325 | |
| 0.018 | 0.009 | 0.018 | Vitamin D receptor agonist | 0.018 0.008 CID_253325 | ||
| 0.042 | 0.033 | 0.042 | Liver X receptor agonist | |||
| 0.039 | 0.031 | 0.039 | Liver X receptor alpha agonist | |||
| 0.193 | 0.187 | 0.193 | Antithrombotic | |||
| 0.091 | 0.089 | 0.091 | GABA receptor agonist | |||
| 0.02 | 0.018 | 0.02 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.066 | 0.064 | 0.068 | CDC25A inhibitor | 0.068 0.06 CID_253325 | CID_253325 | |
| 0.187 | 0.185 | 0.187 | Angiogenesis inhibitor | |||
| 0.016 | 0.022 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.017 CID_253325 | CID_253325 | |
| 0.039 | 0.096 | 0.106 | HIV-1 integrase (3'-Processing) inhibitor | 0.106 0.024 CID_253325 | CID_253325 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |